4.8 Article

Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer

Journal

NATURE CHEMICAL BIOLOGY
Volume 3, Issue 8, Pages 498-507

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nchembio.2007.10

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA113890, U01 CA091178] Funding Source: Medline
  2. NIGMS NIH HHS [P50-GM067082] Funding Source: Medline

Ask authors/readers for more resources

The heat shock protein 90 (Hsp90) has a critical role in malignant transformation. Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood. By using selective compounds, we have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90. Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled. These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available